PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 152 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $16,000 | -38.5% | 4,277 | -11.4% | 0.00% | – |
| Q4 2019 | $26,000 | +160.0% | 4,830 | +156.1% | 0.00% | – |
| Q3 2019 | $10,000 | -63.0% | 1,886 | -56.5% | 0.00% | – |
| Q2 2019 | $27,000 | +50.0% | 4,338 | +15.5% | 0.00% | – |
| Q1 2019 | $18,000 | +20.0% | 3,757 | +10.3% | 0.00% | – |
| Q4 2018 | $15,000 | 0.0% | 3,407 | +45.6% | 0.00% | – |
| Q3 2018 | $15,000 | -21.1% | 2,340 | +1.1% | 0.00% | – |
| Q2 2018 | $19,000 | +46.2% | 2,315 | +24.7% | 0.00% | – |
| Q1 2018 | $13,000 | +18.2% | 1,857 | -0.3% | 0.00% | – |
| Q4 2017 | $11,000 | +266.7% | 1,862 | +375.0% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 392 | -11.9% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 445 | +45.9% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 305 | -45.7% | 0.00% | – |
| Q2 2016 | $2,000 | -33.3% | 562 | -3.6% | 0.00% | – |
| Q1 2016 | $3,000 | -89.3% | 583 | -87.2% | 0.00% | – |
| Q4 2015 | $28,000 | +7.7% | 4,563 | 0.0% | 0.00% | – |
| Q3 2015 | $26,000 | -23.5% | 4,563 | +0.4% | 0.00% | – |
| Q2 2015 | $34,000 | +30.8% | 4,544 | +5.4% | 0.00% | – |
| Q1 2015 | $26,000 | -21.2% | 4,311 | -1.1% | 0.00% | – |
| Q4 2014 | $33,000 | +43.5% | 4,361 | -2.2% | 0.00% | – |
| Q3 2014 | $23,000 | +27.8% | 4,461 | 0.0% | 0.00% | – |
| Q2 2014 | $18,000 | +5.9% | 4,461 | +7.5% | 0.00% | – |
| Q1 2014 | $17,000 | -29.2% | 4,150 | -2.4% | 0.00% | – |
| Q4 2013 | $24,000 | +9.1% | 4,250 | 0.0% | 0.00% | – |
| Q3 2013 | $22,000 | +22.2% | 4,250 | +4.9% | 0.00% | – |
| Q2 2013 | $18,000 | – | 4,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|